What are the risk factors for gastric lymphoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Risk Factors for Gastric Lymphoma

The primary risk factor for gastric lymphoma, particularly MALT (mucosa-associated lymphoid tissue) lymphoma, is chronic Helicobacter pylori infection, which accounts for approximately two-thirds of cases. 1

Primary Risk Factors

Helicobacter pylori Infection

  • Most significant established risk factor for gastric MALT lymphoma 1, 2
  • Bacterial colonization triggers lymphoid infiltration and formation of acquired MALT 3
  • H. pylori induces and sustains actively proliferating B-cell populations through both direct (autoantigen) and indirect (intratumoral T cells specific for H. pylori) immunological stimulation 3
  • The infection provokes neutrophilic response causing release of oxygen free radicals, which may promote genetic abnormalities and malignant transformation of reactive B cells 3
  • Detected in approximately 42-61% of gastric MALT lymphoma patients at diagnosis 4

Immunosuppression

  • Post-solid organ transplantation increases risk 5, 2
  • HIV infection is an established risk factor 5, 2

Autoimmune and Inflammatory Conditions

  • Celiac disease predisposes to GI lymphoma 5, 6
  • Inflammatory bowel disease increases risk 5, 6
  • Autoimmune disorders (including Sjögren syndrome for salivary gland involvement) 7, 6
  • Approximately 5% of gastric MALT lymphoma patients have concurrent autoimmune disease 4

Secondary Risk Factors

Infectious Agents (Beyond H. pylori)

  • Epstein-Barr virus (EBV): Associated with approximately 11% of gastric DLBCL (diffuse large B-cell lymphoma) but rarely seen in MALT lymphoma (2.2%) 8
  • Campylobacter jejuni: Associated with immunoproliferative small intestinal disease (IPSID) 7
  • Chlamydophila psittaci: May be relevant for ocular adnexa lymphomas (varies by geographical distribution) 7
  • Borrelia burgdorferi: Associated with cutaneous MALT lymphomas 7

Chronic Inflammation

  • Chronic gastritis secondary to H. pylori infection is considered the major predisposing factor for MALT lymphoma development 2
  • Conditions causing accelerated cell turnover and chronic inflammation may lead to malignant transformation of gut lymphocytes 6

Important Clinical Context

The stomach is the most common site for extranodal non-Hodgkin lymphoma, accounting for 30-40% of all extranodal lymphomas in the Western world 1, 6. The incidence of primary gastric lymphoma is increasing, in contrast to gastric carcinomas 9.

Genetic Factors

While not traditional "risk factors," certain genetic abnormalities influence disease behavior:

  • t(11;18)(q21;q21) translocation creates H. pylori-independent growth 3
  • Trisomy 3 and microsatellite instability are associated with H. pylori-dependent tumors 3
  • These genetic changes occur after initial H. pylori-driven transformation

Critical caveat: The presence of H. pylori infection must be confirmed through multiple methods if histochemistry is negative, including serology, urea breath test, and/or stool antigen test 1, as occasional lymphoma responses to antibiotic therapy occur even in initially H. pylori-negative cases, possibly due to false-negative tests or infection by other Helicobacter species 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.